baber/WOPTO huggingface dataset:
Patent AU-1786199-A (AU)
Title: Pharmaceutical preparation for inhalation of an opioid
Inventor: VERKERK VOLCMAR
IPC: A61K9/72
Filed: 1998-12-11
Abstract: The present invention relates to the inhalation of opioids, such as morphine, administered as a dry powder. Opioids administered as dry powder for inhalation are intended for local treatment in the respiratory tract, or for systemic treatment following absorption in the lungs and airways. Indications for opioids dry powder per inhalation include the treatment of dyspnoea and pain. Opioids as dry powder for inhalation may be administered with the use of an inhaler, which can be described as a multi-dose reservoir system such as the Cyclovent(TM), or a premetered single-dose system such as the cyclohaler(TM), or a premetered disposable system as the Disphaler(TM).
Patent AU-1916202-A (AU)
Title: Highly weatherable moisture-curable one-component polyurethane compositions
Inventor: SUGIYAMA AKIRA
IPC: C08K5/5455
Filed: 2001-12-07
Abstract: Highly weatherable, moisture-curable, one-component polyurethane composition which is curable with moisture in the air is provided at lower costs. The composition contains a main component which will form a polyurethane resin upon curing, and additives. The additives are one or more photocurable materials selected from the group consisting of unsaturated acrylic compounds, polyvinyl cinnamate, and azide-containing compounds; and a hindered amine photostabilizer. The additives may preferably further contain a thixotropy endowing agent comprising a blocked amine compound forming primary or secondary amino group with moisture, or a polyurea compound.
Patent AU-1962688-A (AU)
Title: Prevention and treatment of retroviral disease
Inventor: SALK JONAS
IPC: C07K16/00
Filed: 1988-06-09
Abstract: The present invention provides a non-infectious immunogen containing retroviral particles devoid of outer envelope proteins or containing selected antigens isolated from a retrovirus. There is also provided a vaccine effective against HIV. In one aspect, the immunogen is useful for immunizing an individual previously infected by a retrovirus including HIV, so as to induce immunoprotective factors protective against progression of the infection. In another aspect, the vaccine is useful for vaccinating an individual not previously infected with HIV in order to prevent subsequently acquired infection. In another aspect, there is provided a method of rendering a viral immunogen non-infectious. The immunogen may also be used to produce antibodies for passive immunotherapy, alone or in conjunction with active immunotherapy, in individuals infected with a retrovirus, including HIV, preferably those individuals exhibiting low levels of antibodies to retroviral gene products other than the outer envelope.
Patent AU-2013197-A (AU)
Title: Methods of preventing or reducing bacterial translocation
Inventor: DAYNES RAYMOND A
IPC: A61K31/56
Filed: 1997-05-08
Abstract: PCT No. PCT/US94/02558 Sec. 371 Date Aug. 9, 1994 Sec. 102(e) Date Aug. 9, 1994 PCT Filed Mar. 8, 1994 PCT Pub. No. WO94/20111 PCT Pub. Date Sep. 15, 1994.The present invention is directed to a method for preventing or reducing ischemia following injury, such as reperfusion injury following ischemia, cellular damage associated with ischemic episodes, such as infarctions or traumatic injuries, and thus to prevent or reduce the consequent progressive necrosis of tissue associated with such ischemia. This effect is achieved by administering DHEA or DHEA derivatives to a patient as soon as possible after the injury. The present invention is further directed to methods for preventing or reducing bacterial translocation or adult respiratory distress syndrome in a patient. Similarly, bacterial translocation and adult respiratory distress syndrome are prevented or reduced by administering DHEA or DHEA derivatives to a patient. Suitable derivatives of DHEA include, among others, 16 alpha -bromo-DHEA, androstenediol and derivatives which have side chains at the 4' and/or 7' positions, which do not destroy the native activity of DHEA but which are capable of inhibiting sulfotransferase to prevent the conversion of DHEA to DHEA-S.
Patent AU-2191497-A (AU)
Title: Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
Inventor: HUDKINS ROBERT L
IPC: A61P25/16
Filed: 1997-02-20
Abstract: Disclosed in this patent document are synthetic, biologically active molecules referred to as fused pyrrolo[2,3-c]carbazole-6-ones. These molecules are represented by the following general formulae:   using the fused pyrrolo[2,3-c]carbazole-6-ones are also disclosed.
Patent AU-2291192-A (AU)
Title: Pattern sheets
IPC: B27M3/06
Filed: 1992-06-29
Abstract: Bar pattern sheets having many parallel rows of bars, the bars in adjoining rows being mutually offset in the longitudinal direction, which sheets are used for production of a panel to be cut into a floor boards each containing b rows of bars. The pattern sheets comprise a x b rows of bars. The left end bars in each row being designated V1, V2, etc and the right end bars H1, H2 etc. The patterns on the left end bars and the right end bars with the same ordinal numbers for example V1 and H1 on at least one row of bars of each board match each other.
Patent AU-2297195-A (AU)
Title: Rtv silicone compositions using aminohydrocarbyl-substituted ketoximinosilanes
Inventor: KNEPPER JEFFREY ALAN
IPC: C08L83/06
Filed: 1995-04-24
Abstract: A room temperature vulcanizable silicone rubber composition with crack resistant properties with improvement during cure, comprising a silanol end-stopped diorganopolysiloxane polymer; a methyl tris-(methyl ethyl ketoximino)silane crosslinker, an aminohydrocarbyl substituted ketoximinosilane adhesion promoter; a reinforcing or non-reinforcing filler or filler mixture, and an optional catalyst and plasticizer. These compositions cure to elastic materials useful as caulking materials, adhesives, coatings and encapsulating materials for the construction and other industries.
Patent AU-2305002-A (AU)
Title: Printable complex security support and method for making same
Inventor: VALLEE ANTOINE
IPC: B32B27/12
Filed: 2001-11-09
Abstract: The invention concerns a printable complex security support characterised in that it comprises a polyester film (1), having an inner surface (1a) and an outer surface (1b), and another polyester film (3), having an inner surface (3a) and an outer surface (3b), between which is inserted a nonwoven fabric (2), having a surface (2a) and a surface (2b), said nonwoven fabric consisting of fibres and/or filaments being mechanically resistant, in particular to tearing and to heat. The invention also concerns the method for making said support and the security document comprising it, in particular a banknote.
Patent AU-2321799-A (AU)
Title: Enzymatic conversion of gdp-mannose to gdp-fucose
Inventor: SJOBERG ERIC R
IPC: C12N15/61
Filed: 1999-01-15
Abstract: This invention provides methods for practical enzymatic conversion of GDP-mannose to GDP-fucose. These methods are useful for efficient synthesis of reactants used in the synthesis of fucosylated oligosaccharides.
Patent AU-2370095-A (AU)
Title: Ropeway safety monitoring system
Inventor: FROHLICH SIGURD
IPC: B61B12/06
Filed: 1995-04-28
Abstract: Sensors distributed along a ropeway communicate with a base station and preferably a base station computer. One type of sensor detects and signals cable misalignments from a normal line of cable traction. Preferably each cable tower has at least one such sensor. Another type of sensor is mounted on a sheave assembly and detects vibrations characteristic of disintegration within the assembly. It produces a sheave problem signal whenever such occurs. Preferably there is one vibration sensor mounted on each sheave assembly. Another type of sensor is preferably mounted on each ropeway carrier for detecting and signaling excessive swings. The sensor signals are communicated to a cable operator so that remedial action can be taken. Each carrier sensor has an RF transmitter for broadcasting its signals to RF receivers mounted on cable towers. Interface units local to sensor groups relay their signals to a base station computer that provides corresponding indicators to the cable operator. Preferably ropeway carrier transmitters and tower receivers are spread spectrum for immunity from outside interference. Preferably the interface units and the base computer communicate via a common data network. Each carrier can also have one or more code transponders which communicate certain unique codes to the base station each time the carrier passes by the station.
Patent AU-2444984-A (AU)
Title: Pressure relief valve
Inventor: BORK CARL RICHARD
IPC: F16K17/04
Filed: 1984-02-10
Abstract: A pressure relief valve comprising a valve body (A) having inlet and outlet ports (12, 16) and a bonnet (B) having a threaded projection (46) which is received in a threaded bore (20) in the valve body (A), said bonnet (B) having a poppet guide bore (66) extending into said projection (46) from a bonnet end surface (48) on said projection (46), and a poppet (H) slidably guided between closed and open positions for respectively closing and opening said inlet port (12), having first and second recesses (68, 70) extending into said projection (46) from said bonnet end surface (48) coaxially with said poppet guide bore (66), a seal ring (72) is positioned in said first recess (68) in surrounding sealing relationship with said poppet (H) and a pushin retainer (74) is secured in said second recess (70) for retaining said seal ring (72) in said first recess (68).
Patent AU-2595188-A (AU)
Title: Apparatus, apparatus part and method for amplification of nucleic acids
IPC: B01J19/00
Filed: 1988-11-25
Abstract: Described is a method for performing the amplification of nucleic acids by incubating in a vessel, in order to perform polymerization, a reaction mixture which contains in a suitable buffer solution one or several single-stranded target nucleic acids, suitable primers, deoxynucleoside triphosphates and a polymerase, whereafter the reaction mixture is transferred, by a procedure suitable in the given case, into another vessel for the denaturation of the nucleic acids, from which vessel, after denaturation, the reaction mixture is transferred back into the original vessel, by using a suitable procedure. The apparatus for performing this method includes one or several, preferably parallel, pairs of vessels. A vessel pair is made up of two vessels (1 and 2) which are interconnected or capable of being interconnected by means of one or several tubes (3). The apparatus may be provided with a separate heat exchanger (4) via which at least one of the tubes (3) passes, or a tube may as such serve as a heat exchanger. Each of the vessels is provided with a thermoregulator (11, 12), for example a heat block provided with a thermostat. Furthermore, the apparatus includes a fluid-transfer system (5-8, 10) for transferring the reaction fluid from one vessel to another. The vessel in which the polymerization occurs may be equipped with a suitable dosing device (9) for the adding of the polymerase and/or reagents. By using this apparatus it is possible fully automatically, without separate steps requiring an operator, to perform the amplification of nucleic acids on one or several samples simultaneously, under standardized reaction conditions.
Patent AU-2620088-A (AU)
Title: Tar-spray with valve
Inventor: BURGGRAAFF TEUNIS
IPC: B05B1/30
Filed: 1988-11-02
Abstract: The invention regards a needle valve with spray nozzle for spraying hot tar or bituminous liquids on roads. For this purpose the spray-nozzle (3, 4) is also the seating of the valve. The valve-needle (11) is activated by compressed air in a pneumatic cylinder (7) with returning spring (16). The sealing of the valve-needle (11) to the pneumatic cylinder (7) is guaranteed by means of a flexible sleeve (22), attached to the valve-needle (11) and a protuberant extention (10) of pneumatic cylinder (7).
Patent AU-2705092-A (AU)
Title: Closure cap with seal and method and apparatus for forming such closure seal
IPC: B29C67/00
Filed: 1992-10-15
Abstract: In combination, a container and a linerless cap and a method of forming the cap. In the method the cap is molded from plastic and includes a top well, an outer depending skirt and an internal depending substantially annular wall having an upper end integral with and depending from the top wall and a lower free end. Thereafter the free end is engaged by a curling tool to progressively turn the free end away from the internal wall to curve the free end into a curvilinear compressible and resilient free end adapted to be engaged for sealing. The engageable free end of the seal can have a coil, O, U, J or quarter round cross sectional shape and can be a rim, plug or corner seal.
Patent AU-2709799-A (AU)
Title: Method and device for coating sheets and use of said method
Inventor: RIEDENER PHILIPP
IPC: B41F15/08
Filed: 1999-03-23
Abstract: A device for coating a sheet comprises at least one screen cylinder configured to be positioned downstream of a sheet feeding mechanism. The screen cylinder is further configured to coat a sheet. The device further comprises a constant conveyor for feeding a sheet from the feeding mechanism to the screen cylinder and a variable speed drive for rotating the screen cylinder. The variable speed drive is configured to rotate the screen cylinder based on one of a print length and a print position of the sheet to be coated.
Patent AU-2739095-A (AU)
Title: Power control method and arrangement for handover in a mobile communication system
Inventor: AALTO RISTO
IPC: H04B7/005
Filed: 1995-06-12
Abstract: PCT No. PCT/FI95/00340 Sec. 371 Date Dec. 12, 1996 Sec. 102(e) Date Dec. 12, 1996 PCT Filed Jun. 12, 1995 PCT Pub. No. WO95/35003 PCT Pub. Date Dec. 21, 1995For providing power control for a mobile station in a mobile communication, in connection with accomplishing a handover of the mobile station from a presently serving cell to a target cell, each cell is assigned a maximum transmitting power level at which mobile stations are allowed to transmit in the cell. The receive level of the downlink signal of the handover target cell is measured at the mobile station prior to the handover, and the transmitting power level of the measured receive level of the downlink signal of the target cell. The mobile station is commanded to use the determined transmitting power level as its initial output power level in the target cell following the handover. The transmitting power level of the mobile station following the handover is lower than the maximum transmitting power level of the target cell by an amount equal to the difference between the optimum level of the uplink signal of the target cell and the measured receive level of the downlink signal of the target cell as measured prior to the handover, if the measured receive level of the target cell is higher than the optimum level of the uplink signal of the target cell.
Patent AU-2821397-A (AU)
Title: Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
Inventor: NAIR SMITA K
IPC: C07K14/77
Filed: 1997-04-30
Abstract: The present invention relates to methods for producing an RNA-loaded antigen presenting cell (APC), said method comprising introducing into an antigen presenting cell  in vitro  RNA encoding an immunomodulator. The present invention also relates to RNA-loaded APCs obtainable by such methods.
Patent AU-2870284-A (AU)
Title: Fiber-optic transducer apparatus
Inventor: KNUTE WALLACE L
IPC: A61B5/02
Filed: 1984-05-25
Abstract: A fiber-optic transducer apparatus, and a related method of manufacturing it, for particular use in medical applications such as invasive blood pressure and body temperature measurement. The apparatus includes a catheter comprised of a sheath and an enclosed first set of optical fibers for transmitting a light beam to and from the remote end of the catheter, where a transducer modulates it in accordance with the variable to be measured, e.g., blood pressure. A photosensor located at the near end of the catheter measures the modulated intensity of the returned beam, to produce a corresponding measurement signal. The catheter is further comprised of a second set of optical fibers located within the sheath, for transmitting a reference light beam to and from the remote end of the catheter. A second photosensor measures the intensity of the returned reference light beam, to produce a correction signal indicative of variations in transmittance caused by bending of the catheter. It is presumed that the effects of such bending are the same for the second set of optical fibers as for the first set, so the apparatus adjusts the measurement signal in accordance with the correction signal, to produce an adjusted measurement signal that is substantially insensitive to the effects of such bending.
Patent AU-3138593-A (AU)
Title: Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
IPC: A61P13/12
Filed: 1992-11-13
Abstract: The present invention provides a method of inhibiting an activity of a cell regulatory factor comprising contacting the cell regulatory factor with a purified polypeptide, wherein the polypeptide comprises the cell regulatory factor binding domain of a protein and wherein the protein is characterized by a leucine-rich repeat of about 24 amino acids. In a specific embodiment, the present invention relates to the ability of decorin, a 40,000 dalton protein that usually carries a glycosaminoglycan chain, to bind TGF- beta . The invention also provides a novel cell regulatory factor designated MRF. Also provided are methods of identifying, detecting and purifying cell regulatory factors and proteins which bind and affect the activity of cell regulatory factors. The present invention further relates to methods for the prevention or reduction of scarring by administering decorin or a functional equivalent of decorin to a wound. The methods are particularly useful for dermal wounds resulting from burns, injuries or surgery. In addition, the present invention includes pharmaceutical compositions containing decorin or its functional equivalent and a pharmaceutically acceptable carrier useful in such methods. Finally, methods for preventing or inhibiting pathological conditions by administering decorin are also provided. <IMAGE>   <IMAGE>
Patent AU-3218600-A (AU)
Title: Self-generation of certificates using a secure microprocessor in a device for transferring digital information
Inventor: MEDVINSKY SASHA
IPC: G06F21/20
Filed: 2000-01-28
Abstract: A system for establishing a secure communication channel between a first user (102) and a second user (112) in an IP telephony network. The first user and the second user are coupled to first (104) and second (114) telephony adapters, which in turn, are coupled to first (106) and second (116) gateway controllers, respectively, wherein the gateway controllers control user access to the IP telephony network. The telephony adapters are used to encrypt and decrypt user information exchanged over the IP telephony network. The system includes a method which begins when a request is received at the first gateway controller to establish a secure communication channel between the first user and the second user. Next, a secret key (408) is generated at the first gateway controller. A copy of the secret key is distributed to the first and second telephony adapters over previously established secure connections. Finally, the secure communication channel is established (422) between the first user and the second user by encrypting and decrypting information using the secret key.
Patent AU-3317989-A (AU)
Title: Trifluoromethylphenylpyrinidinones
Inventor: PERRIOR TREVOR ROBERT
IPC: C07C211/52
Filed: 1989-04-19
Abstract: Insecticidal compounds of formula (I) <CHEM> wherein R<1> and R<2> are independently selected from halogen or nitro; R<3> and R<4> are independently selected from hydrogen or halogen; R<5> is hydrogen, halogen or cyano; and R<6> is halogen or haloalkyl; provided that R<1>, R<2>, R<3> and R<4> are not all fluorine.
Patent AU-3432600-A (AU)
Title: Anti-tartar dental product and related method
Inventor: WILLIAMS DAVID
IPC: A61K8/86
Filed: 2000-03-28
Abstract: An oral product and method is provided for inhibiting tartar formation on the teeth. The product is housed in a container and includes a first composition containing a water soluble calcium phosphate salt or monolithic combination of calcium and phosphate salts in a carrier with the first composition having a pH less than 7, and a second composition containing an alkaline material and a fluoride ion source in a carrier to achieve a pH greater than 7.5. The first and second compositions are separated from one another prior to use. When combined upon application to the teeth, the first and second compositions form a system for inhibiting tartar around the teeth.
Patent AU-3657699-A (AU)
Title: Apparatus and method for measuring vision defects of a human eye
Inventor: LIANG JUNZHONG
IPC: A61B3/103
Filed: 1999-04-20
Abstract: Optical characteristics of optical systems, such as the eye, are measured including vision defects of the eye using a collimated beam from a diode laser focused onto the anterior surface of the cornea of the eye for providing a finite source of secondary radiation on the retina of the eye, the image of which is close to a desired diffraction limited spot. The secondary radiation is reflected back from the retina as a reflected wavefront of radiation that passes through the eye and is directed onto a wavefront analyzer where distortions associated with the reflected wavefront are measured. By focusing on the cornea through a long focal length lens and thus converging the beam through a small angle, as opposed to typically focusing a collimated light onto the retina, the need for lenses or lens combinations, and the time required to adjust such to accommodate the differing vision of each patient is eliminated.
Patent AU-3695784-A (AU)
Title: 1-Aryl-2-fluoro-2-azolylalkanones and derivatives thereof
Inventor: FRICK WILLY
IPC: C07D249/08
Filed: 1984-12-19
Abstract: The invention relates to 1-aryl-2-fluoro-2-azolyl alkanones, alkanols, esters and ethers of formula I    <IMAGE>  (I)  wherein Az is 1H-1,2,4-triazole, 4H-1,2,4-triazole or 1H-imidazole; T is -C(O)-, -CH(OH)- or one of the groups   <IMAGE>  wherein R7 is C1-C6alkyl which is unsubstituted or substituted by C1-C3-alkoxy, halogen or cyano, or is C3-C6alkenyl, C3-C6alkynyl, C3-C6cycloalkyl, 2-furyl, 2-tetrahydrofuryl, or is phenyl or benzyl, each unsubstituted or substituted by halogen, nitro, C1-C3-alkyl, C1-C3alkoxy, C1-C3haloalkyl and/or C1-C3haloalkoxy; R8, R9 and R10 are each independently hydrogen, nitro, halogen, cyano, C1-C3alkyl, C1-C3alkoxy, C1-C3haloalkoxy, -COO(C1-C3alkyl), NH2 or NHCOCH3; R is hydrogen or C1-C6alkyl; R1 and R2 are each independently hydrogen, halogen, C1-C6alkyl, C1-C6-alkoxy, C1-C6haloalkyl, C1-C6haloalkoxy, nitro and/or cyano; and R3 is hydrogen, halogen, C1-C6alkyl, C1-C6alkoxy, C1-C6haloalkyl, C1-C6 haloalkoxy, nitro, cyano and/or the group   <IMAGE>  wherein X is O, S, SO or SO2; R4, R5 and R6 are each independently hydrogen, halogen, cyano, nitro, C1-C6alkyl, C1-C6alkoxy, C1-C6haloalkyl and/or C1-C6haloalkoxy; and to the acid addition salts and metal complexes thereof. These compounds have microbicidal properties and can be used in particular against diseases occurring in rice. The invention also relates to the preparation and use of these compounds.
Patent AU-3721084-A (AU)
Title: Phenyl acetic acid amides
Inventor: GRELL WOLFGANG
IPC: A61K31/395
Filed: 1984-12-28
Abstract: 1. Two new solid forms of 2-ethoxy-4-[N-(1-(2-piperidino- phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid, the form designated (B) being characterised by the melting point of 140-142 degrees C and by the IR(KBr) spectrum according to Figure B' and the form designated (C) being characterised by a melting point of 75-85 degrees C and by the IR(KBr) spectrum according to Figure C'.